A revolutionary gene therapy treatment for cancer

[SSH Shamma]

Kymriah is a newly FDA-approved cancer gene therapy treatment from the drug company Novartis. It's part of a new class of therapy called CAR-T, which is made by "harvesting a patient's own disease-fighting T-cells, genetically engineering them to target specific proteins on cancer cells, and replacing them to circulate possibly for years, seeking out and attacking cancer," according to Reuters.

It's not cheap — it costs $475,000 per patient — but the results in patients with aggressive blood cancer are unprecedented. In fact, 83 percent of patients were cancer-free after three months with one dose (they continued to respond after six months, according to new reports).

[munira.ete]

Thanks for sharing.